Tomorrow morning, June 29th. I have a feeling they are having major discussions with the FDA OR there is a deadline in place for deal acceptance. I doubt very much that they are just now reviewing the data and pondering what to say on a press release. I think this is going to be very serious business. High level discussions with the FDA and/or partnership deal deadline. BOOOM.
I think that's a solid option.
PUMA's efficacy data is probably statistically significant, but clinically significant??
Longs, one SUPER KEY trigger point this week. Long time waiting.
Looked at phase I, II and phase III data: this part of the dossier ready to submit.
Phase II data, sub analyses with dose/booster and response rate=ready to submit.
All biomarkers studies published: solid irrefutable data ready to submit file.
Mechanism of action of neuvax: solid and irrefutable data ready to submit.
Manufacturing data: ready to submit.
Phase III, interim: efficacy for the first 70 events ready to submit. Will the score be 10/60 events in favor of Neuvax, triggering halt? We are close to finding out.
Thief, you forgot to mention this:The positive outcome from the IDMC’s review of the ADAPT trial data triggers the second tranche of the financing under the Company’s previously announced March 2016 securities purchase agreement. Upon the closing of the second tranche, which is expected to occur within 30 days, the Company will receive a total of $29,824,520 from the sale of a total of 5,478,672 shares of common stock and warrants to purchase a total of 4,109,005 shares of common stock.
Difficult to answer. It all depends what the interim analysis gives us. Halt for efficacy? 5Bmarket cap. Non futility and BLA submission? 2B valuation.
A total idiot. You watch him publish detailed analyses on trials during key conferences. he can't go through detailed trial data without being fed by the company marketing/PR dudes. Impossible. May I ad that many times, it's embargoed data..so, how does he have access to the details of what a principal investigator of the trial has and be able to publish articles the day the embargo is lifted? Anybody noticed? He has a personal agenda. He has too much publicity here.